Skip to main content

Month: April 2020

Bellerophon Therapeutics Submits Investigational New Drug Application to Study INOpulse® Inhaled Nitric Oxide Therapy for the Treatment of COVID-19

WARREN, N.J., April 08, 2020 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today announced the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to study the INOpulse® inhaled nitric oxide system (iNO) for the treatment of patients infected with COVID-19. INOpulse is the only therapy to deliver targeted nitric oxide by autonomously adjusting to the patient’s breathing pattern to ensure accurate and consistent drug delivery into the airways. The proposed randomized, open-label study, called PULSE-CVD19-001, will evaluate the efficacy and safety of INOpulse in patients with COVID-19 who require supplemental oxygen. The PULSE-CVD19-001 protocol utilizes...

Continue reading

Overstock Granted DTC Eligibility for Digital Voting Series A-1 Preferred Stock

SALT LAKE CITY, April 08, 2020 (GLOBE NEWSWIRE) — Overstock.com, Inc. (NASDAQ:OSTK) announces that, as expected, The Depository Trust Company (DTC) granted eligibility to the company’s Digital Voting Series A-1 Preferred Stock, OSTKO, on April 7, 2020. DTC eligibility allows shares of OSTKO to be eligible for depository and book-entry services at DTC. “This is a long-awaited moment for Overstock and our shareholders, as DTC’s grant of eligibility removes a hurdle to issuing our innovative digital dividend,” said Overstock CEO Jonathan Johnson. “DTC eligibility will make the dividend easier for broker dealers to process on behalf of our shareholders.”Overstock expects NASDAQ to issue an ex-dividend date in the coming days.The company continues to provide detailed information on the divided, including a timeline and answers to frequently...

Continue reading

On Point Exceeds 12 Million Views on Crackle

COS COB, Conn., April 08, 2020 (GLOBE NEWSWIRE) — Chicken Soup for the Soul Entertainment Inc. (Nasdaq: CSSE), one of the largest operators of streaming advertising-supported video-on-demand (AVOD) networks, today announced that the Crackle Original basketball docuseries On Point has driven over 12 million views since its February 13th launch.The 10-part docuseries offers a behind-the-scenes look at the high-stakes world of prep and Amateur Athletic Union (“AAU”) basketball, a proving ground for top NBA players for the last several decades. On Point spotlights Romeo Langford, who is now a member of the NBA’s Boston Celtics and Scottie Lewis, now at the University of Florida, among other talented young players. Notable appearances in the series include NBA stars Kevin Durant, Steph Curry, and Zion Williamson.“We are delighted with...

Continue reading

Vericel to Present at the 19th Annual Needham Healthcare Conference on Tuesday, April 14, 2020

CAMBRIDGE, Mass., April 08, 2020 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, president and CEO, will present the latest company overview at the 19th Annual Needham Healthcare Conference. The conference is being conducted with a virtual format and the presentation will take place on Tuesday, April 14, 2020 at 1:30pm Eastern Time.A live webcast of the presentation will be available on the Investor Relations section of the Vericel Corporation website at: http://investors.vcel.comAbout Vericel CorporationVericel is a leader in advanced therapies for the sports medicine and severe burn care markets. The company markets two cell therapy products in the United States. MACI® (autologous cultured chondrocytes...

Continue reading

Passage Bio to Present at 19th Annual Needham Healthcare Conference

PHILADELPHIA, April 08, 2020 (GLOBE NEWSWIRE) — Passage Bio, Inc. (NASDAQ: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, today announced that management will present at the virtual 19th Annual Needham Healthcare Conference on Wednesday, April 15, 2020 at 12:50pm ET.A live audio webcast of the presentation will be available on the Investors & Media section of Passage Bio’s website at investors.passagebio.com. A replay of the webcast will be available for 30 days following the presentation.About Passage BioPassage Bio is a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company is based in Philadelphia, PA and...

Continue reading

Slinger Bag Partners with Leading Distribution Company Globeride Inc. to Access the World’s Second Largest Tennis Market

Five year agreement includes exclusive distribution partnershipBALTIMORE, April 08, 2020 (GLOBE NEWSWIRE) — Slinger Bag Inc. (OTC: SLBG), a sports brand focused on innovating game improvement equipment for all ball sports (“Slinger Bag” or “Company”), with an initial focus on the global tennis market, has announced its inaugural global distribution agreement with the leading Japanese sporting equipment distributor, Globeride Inc.The partnership names Globeride Inc. as the exclusive distributor of Slinger Bag products in the Japanese market including its new Slinger Launcher Bag – a major innovation in the global tennis market. Globeride plans to launch the Slinger Bag brand to Japanese consumers from July 2020.Tennis is growing at a serious speed across Asia and Japan is recognized as the second largest global market for the...

Continue reading

Auxly Acquires Exclusive Global Rights to Omega-Rich Ahiflower® Seed Oil for Use in Cannabis Products

TORONTO, April 08, 2020 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly” or the “Company”), a leading consumer packaged goods company in the derivative cannabis market, is pleased to announce that its wholly owned subsidiary Dosecann LD Inc. (“Dosecann”) has entered into an agreement with Natures Crops International (“Natures Crops”), a vertically integrated grower and manufacturer of plant-based specialty oils, pursuant to which the Company will purchase the exclusive global rights to Ahiflower® oil for use in Auxly’s diverse portfolio of cannabis products. This multi-year deal will provide Auxly with a proprietary ingredient for use in its current portfolio of cannabis products and the development of next generation cannabis health products that Auxly will commercialize when legally permitted.“Auxly...

Continue reading

Gentherm Announces Date for 2020 First Quarter Results News Release and Conference Call

NORTHVILLE, Mich., April 08, 2020 (GLOBE NEWSWIRE) — Gentherm (NASDAQ:THRM), a global market leader and developer of innovative thermal management technologies, will report its financial results for the first quarter 2020, at 6:00 a.m. (ET) on Thursday, May 7, 2020, and will host a conference call to discuss those results at 8:00 a.m. (ET) that same day.Conference CallToll-free dial-in number: 1-877-407-4018International dial-in number: 1-201-689-8471Conference ID number: 13701725WebcastA live webcast and one-year archived replay of the call can be accessed on the Events page of the Investor Relations section of Gentherm’s website at www.gentherm.com.  A telephonic replay will be available approximately 2 hours after the call by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live...

Continue reading

MICHAEL DURANCE JOINS YANGAROO’S BOARD OF DIRECTORS

TORONTO, April 08, 2020 (GLOBE NEWSWIRE) — YANGAROO Inc. (TSX-V:YOO, OTBB:YOOIF, the “Company”, “Yangaroo”), the software leader in work flow management and media distribution solutions, today announced that Michael Durance has been appointed to its board of directors, effective today. Michael will also serve on Yangaroo’s Audit and Compensation Committees.Michael is the CEO and Managing Director of xiVentures Fund Inc (“xiVentures”). xiVentures is a Toronto, Canada based boutique venture investment fund focused on select quality technology opportunities. Michael has over 25 years of experience in executive leadership and capital markets in the technology industry.“Michael brings exceptional technology industry expertise and broad capital markets knowledge to Yangaroo’s board of directors,” said Gary Moss, President and CEO of YANGAROO...

Continue reading

Leading International Artist Fair, The Other Art Fair, Introduces ‘Online Studios’ to Spotlight Artists Across the Globe

SANTA MONICA, Calif., April 08, 2020 (GLOBE NEWSWIRE) — The Other Art Fair presents Online Studios, a new digital art experience created in partnership with global online art gallery Saatchi Art. Debuting Wednesday, April 8, Online Studios gives art lovers around the world the opportunity to discover and buy artwork from The Other Art Fair’s 800+ exhibiting independent artists. Over the course of 4 weeks, Online Studios will roll out city-specific features in line with the original Spring Fair schedule. The Other Art Fair and Saatchi Art are united by a shared mission to help audiences discover art—whether in person or online—and support independent emerging artists around the world.With the postponement of its Spring fairs, The Other Art Fair sought alternative ways to support the independent artist community during this difficult...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.